Placental ischemia induces changes in gene expression in chorionic tissue

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Genomics and Molecular Biology

Background:

• Preeclampsia is a major hypertensive disorder in pregnancy, affecting 5-8% of pregnancies globally.
• Placental ischemia is the suspected primary cause, leading to pathogenic factors entering maternal circulation.
• The full spectrum of these pathogenic factors and their molecular impact on placental tissue remains incompletely understood.

Purpose of the Study:

• To investigate the molecular effects of chronic placental ischemia on chorionic tissue and placental villi.
• To identify differentially expressed genes and affected pathways in a preclinical model of preeclampsia.
• To elucidate novel molecular mechanisms contributing to preeclampsia pathogenesis.

Main Methods:

• Utilized the reduced uterine perfusion pressure (RUPP) rat model to simulate placental ischemia.
• Isolated placental and chorionic tissues on gestational day 19 from control and RUPP rats.
• Performed microarray analysis to assess differential gene expression, followed by qRT-PCR validation.

Main Results:

• Identified 2,557 differentially regulated genes (p < 0.05) between control and RUPP groups.
• A subset of 22 genes showed >50% change, with significant upregulation of prolactin genes.
• Network analysis revealed strong impacts on inflammatory pathways, including NF-κB and cytokine signaling.

Conclusions:

• Chronic placental ischemia significantly alters gene expression in placental tissues.
• Novel extracellular remodeling proteins, pro-inflammatory factors, and prolactin gene family members are implicated.
• These findings provide new molecular insights into preeclampsia pathogenesis and potential therapeutic targets.